Skip to main content

GLOBUS MEDICAL INC

corporate_fare Company Profile

GLOBUS MEDICAL INC

GMED·NYSE·Industrial Applications And Services·CIK 0001237831

Globus Medical, Inc. is a medical device company headquartered in Audubon, Pennsylvania, focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders. Founded in 2003, the company provides medical device innovation and services to hospitals, ambulatory surgery centers, and physicians. Globus is an engineering-driven company that develops and commercializes advanced products and procedures. In 2025, Globus launched 9 products and operates across 65 countries worldwide, offering a portfolio of technologies for various musculoskeletal conditions. The company manages its business globally within one reportable segment, but categorizes its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. On September 1, 2023, Globus completed the acquisition of NuVasive, Inc. Under the merger agreement, each outstanding share of NuVasive common stock was converted into the right to receive 0.75 shares of Globus Class A common stock and cash in lieu of fractional shares.

GLOBUS MEDICAL INC (NYSE:GMED) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors GMED SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Stockholders Approve 1 Million Share Increase for Equity Incentive Plan
  • Globus Medical Slides 8% as Revenue Guidance Holds Steady, Nevro Challenges Cited
  • Globus Medical Reports Robust Q1 2026 Financials with 27% Sales Growth and 67% EPS Increase
  • Globus Medical Q1 Revenue Jumps 27%, Beats Estimates, Raises Full-Year EPS Guidance
  • Globus Medical Reports Robust Q1 Performance, Exceeding Expectations and Raising Full-Year EPS Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.94B
Net Income
$537.87M
Diluted EPS
$3.92
Op. Cash Flow
$753.45M
Free Cash Flow
$588.77M
Gross Profit
$1.98B
Operating Income
$479.82M
Cash & Equivalents
$526.16M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
18.3%
Shares Outstanding
135.22M sh
Source: 10-K · filed 2026-02-24 · accession 0001628280-26-011209
Browse all tickers starting with G →
$81.22 +0.83% today
52-week range · as of 2026-06-04 $51.79 – $101.4
Market cap
$10.91B
Volume
1.5M (0.8× avg)
3-mo avg 1.9M
Live data · 2026-06-14 03:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GMED - Latest Insights

GMED
Jun 04, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.00
Real-time Price: $81.22 info
Change: +$1.22 (+2%) info
Market Cap: $10.906B info
GMED
May 08, 2026, 3:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $78.32
Real-time Price: $81.22 info
Change: +$2.91 (+4%) info
Market Cap: $10.906B info
GMED
May 07, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $90.01
Real-time Price: $81.22 info
Change: -$8.79 (-10%) info
Market Cap: $10.906B info
GMED
May 07, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $91.40
Real-time Price: $81.22 info
Change: -$10.18 (-11%) info
Market Cap: $10.906B info
GMED
May 07, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.40
Real-time Price: $81.22 info
Change: -$10.18 (-11%) info
Market Cap: $10.906B info
GMED
Feb 24, 2026, 5:08 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $92.00
Real-time Price: $81.22 info
Change: -$10.78 (-12%) info
Market Cap: $10.906B info
GMED
Feb 24, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $93.00
Real-time Price: $81.22 info
Change: -$11.78 (-13%) info
Market Cap: $10.906B info
GMED
Jan 07, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $98.00
Real-time Price: $81.22 info
Change: -$16.78 (-17%) info
Market Cap: $10.906B info